Drug Enforcement Administration

News

Trump's DOJ reschedules medicinal marijuana, increasing acce...

The US Justice Department has issued an order moving medical marijuana to Schedule III, removing some barriers to access for patients and researchers.

News

Joint MHRA/NICE pathway 'benefits industry over patients'

LSE pharma policy expert contends the MHRA/NICE aligned pathway is weighted towards industry, and calls for an assessment of its impact on the NHS.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Drug Enforcement Administration

Editor's Picks